Mazen Hassanain. Bile duct Cancer Average age 60 years Ulcerative colitis is a common associated condition Subtypes: (1) periductal infiltrating, (2)

Slides:



Advertisements
Similar presentations
Pimp Session: Breast By James Lee, MD.
Advertisements

Speaker Dr. Mohammed Abu Khair IMO, SU-3 Chairman Dr. Md. Ashraf Uddin Associate professor, SU-3.
RESULTS OF RADICAL SURGERY FOR CARCINOMA OF GALLBLADDER DR CHEUNG YUE SUN Department of Surgery Prince of Wales Hospital The Chinese University of Hong.
Revised AJCC Classification of Extrahepatic Bile Duct Tumors.
Great Debates & Updates in GI Malignancies
Martina Rastovac Mentor: A. Žmegač Horvat. Actor Patrick Swayze died after a 20-month battle with pancreatic cancer. He was 57.Patrick Swayze.
62 years old man Main complaint: Back pain at night but not during the day Loss of appettite Weight loss.
Diseases of the Pancreas. 67 y old male with loss of appetite, gradual weight loss and dyspepsia. Recent onset of jaundice and dark urine.
JAUNDICE Index Case Term 2.
Hepatobiliary Anatomy and Pathology
GALLSTONES Tanja Čujić Mentor: A. Žmegač Horvat. Anatomy of gallbladder and extrahepatic biliary tree Bile Helps the body digest fats Made in the liver.
Tumors of the bile ducts
Advances in Hepatobiliary Surgery Jack Matyas, MD, FACS & Keith Nichols, MD, FACS.
Colorectal cancer Khayal AlKhayal MD,FRCSC
Carcinoma of Gallbladder - an update on surgical management Dr Alfred C C Wong, Department of Surgery, Ruttonjee & Tang Shiu Kin Hospital.
J AUNDICE Mohammed Al- Rajeh & Shreef Al- Qahtani.
Biliary Tumors Cholangiocarcinoma and Cancer of the Gall Bladder
BREAST CANCER.
Gallbladder Cancer Reham Khalilieh 4 th year Medical Student Surgical Round- Shaare Zedek Medical Center, Jerusalem.
Biliary Tract Congenital Anomalies Disorders of gallbladder Acute cholecystitis Chronic cholecystitis Disorders of Extra hepatic bile ducts Choledocholithi.
MedPix Medical Image Database COW - Case of the Week Case Contributor: Jason Rexroad Affiliation: Civilian Medical Center.
Colorectal carcinoma Dr.Mohammadzadeh.
Cholestatic liver diseases:
Guzman, Alexander Joseph Hipolito, April Lorraine
CHOLEDOCHAL CYSTS Aswad Habeeb Hameed Al-Obeidy FICMS GE & Hep.
Case Report Patient PP Submitted by:Matthew Clower, MSIV Faculty:Sandra Oldham, MD Date:29 August 2007 Radiological Category:Principal Modality (1): Principal.
DR. WILLIAM OLALIA MATIAS  MAULION  MEDENILLA  MEDINA.
Hepatocellular Carcinoma (HCC). Definition : Hepatocellular carcinoma is a primary malignancy of the hepatocyte, also known as liver cell carcinoma. Types.
LUNG CANCER Dr.Mohammadzadeh. Lung cancer is the leading cancer killer in the United States. Every year, it accounts for 30% of all cancer deaths— more.
Gallbladder & bile duct Carcinoma Dr. m. h.khosravi.
GALLBLADDER TUMORS Aswad H. Al.Obeidy FICMS, FICMS GE&Hep Kirkuk General Hospital.
Behzad Nakhaei, M.D., FICS Fellowship in HepatoBiliary Surgery Mc Gill University RUQ & Upper Abdomen Inflammation & Infection GallBladder & Biliary System.
Histopathology and cytology (MLHC-201) Faculty of allied medical sciences.
Primary Sclerosing Cholangitis
CHOLANGIOCARCINOMA (KLATSKIN TUMOUR). TR, 84 YRS FEMALE, BG- OSTEOARTHRITIS Admitted with painless obstructive jaundice Admitted with painless obstructive.
PANCREATIC CANCER.
Final Diagnosis Pancreatic Cancer. Pancreatic cancer It is a malignant neoplasm of the pancreas. The prognosis is generally poor; less than 5 percent.
Colorectal Cancer. Colorectal cancer - statistics Leading causes of cancer death in the US Male Female Lung – 31% Lung – 25% Prostate – 11% Breast – 11%
Cancer colon.
Gallbladder Schematic of the gallbladder in relation to the liver and biliary tract. Compton, C.C., Byrd, D.R., et al., Editors. AJCC CancerStaging Atlas,
A 58 years old man presents with melena. What would you ask him?
Faisal Al-Saif MBBS, FRCSC, ABS. - Acute Pancreatitis - Chronic Pancreatitis - Pancreatic Tumors - Pancreas Transplant.
Colon Cancer. Multihit Concept Clinical Information Clinical Information 1. Patient identification a. Name b. Identification number c. Age (birth date)
Obstructive Jaundice: A rare cause. A-65-year-old male. Three weeks of jaundice. Upper abdominal pain.
Pancreatic Cancer L. Okolicsanyi G. Morana Pancreas Cancer l 2nd most common GI malignancy l 30,000 cases per year in US l 25,000 deaths per year l 4.
Pancreatic cancer.
CHOLEDOCHAL CYST – A CASE REPORT PRESENTING AUTHOR – DR.K.PRASANNA POST GRADUATE STUDENT, RAJAH MUTHIAH MEDICAL COLLEGE & HOSPITAL (RMMCH), ANNAMALAI UNIVERSITY,
The role of Endoscopy in Gastric Cancer Fergal Donnellan Gastroenterologist VGH.
Gall bladder and Biliary disease Dr.Umit Akyuz Gastroenterology Department Yeditepe University,Istanbul.
Department of Pathology
Chapters 59 & 62 Hepatic and Biliary Neoplasms Lisa Spiguel, MD.
Effect of multiple-phase regional intra-arterial infusion chemotherapy on patients with resectable pancreatic head adenocarcinoma JIN Chen, YAO Lie, LONG.
Interventions for Clients with Colorectal Cancer.
Tumors of the Biliary System. Anatomy Gallbladder Cancer Usually seen in the elderly Diagnosis at advanced stage, unless discovered incidentally during.
Symptoms and Diagnosis in LIVER and BILIARY TRACT DISEASE Koray Topgül, MD, Prof.
담도질환 Biliary stone disease Infectious/inflammatory disease Tumor
Preoperative staging of hilar cholangiocarcinoma by dual-modality PET/CT. DR SIKANDAR YASHODA HOSPITALS HYDERABAD.
Seoul National University Hospital 우상복부 종괴을 주소로 내원 한 65 세 남자환자 서울대학교병원 소화기내과 이상협, 박주경, 윤원재, 이준규 류지곤, 김용태, 윤용범.
Gallbladder Cancer Surgical Management
Prognostic analysis of surgical treatment of peripheral cholangiocarcinoma: Two decades of experience at Chang Gung Memorial Hospital Yi-Yin Jan, Chun-Nan.
See in clinic for resection Histology discussion in SMDT
CBD Stones, Stricture Carcinoma Gall Bladder Cholangiocarcinoma
Pancreatic cancer Ayman Hasan Linjawi, MD, FRCSC,
Cancer colon.
Cholangiocarcinoma Tamar Taddei, MD.
Pancreatic Cancer What you need to know to be able to educate your patients and their families.
Dr. Sura Obay Al-Dewachi
Harmeet Malhi, Gregory J. Gores  Journal of Hepatology 
STOMACH CANCER BY DR: ALI ALWAILY/MD.
Presentation transcript:

Mazen Hassanain

Bile duct Cancer Average age 60 years Ulcerative colitis is a common associated condition Subtypes: (1) periductal infiltrating, (2) papillary or intraductal, and (3) mass forming-nodular Location: 85% extrahepatic

Risk Factors Definite risk factors Primary sclerosing cholangitis (1% per year) Liver fluke infection (Opisthorchis viverrini) Hepatolithiasis (10%) Biliary malformation (10% choledochal cysts, Caroli's) Thorotrast Probable risk factors Hepatitis C Cirrhosis T oxins (dioxin, polyvinyl chloride) Biliary-enteric drainage procedures

Staging

T1: Tumor involving biliary confluence ± unilateral extension to 2° biliary radicles T2 Tumor involving biliary confluence ± unilateral extension to 2° biliary radicles AND Ipsilateral portal vein involvement ± ipsilateral hepatic lobe atrophy T3 Tumor involving biliary confluence + bilateral extension to 2° biliary radicles OR Unilateral extension to 2° biliary radicles with contralateral portal vein involvement OR Unilateral extension to 2° biliary radicles with contralateral hepatic lobe atrophy OR Main or bilateral portal venous involvement

Presentation Obstructive jaundice Cholangitis (10%) Palpable mass Liver cirrhosis Cachexia

Diagnosis Blood work CA19-9: Its sensitivity and specificity for detection of CCA in PSC are 79% and 98%, respectively, at a cutoff value of 129 U/mL. Imaging (US, CT, MRI/MRCP, ERCP, PTC, EUS, PET/CT)

Treatment and prognosis Surgical resection Adjuvant and neoadjuvant treatments Mayo Protocol The average patient with adenocarcinoma of the bile duct survives less than a year. The overall 5-year survival rate is 15%. Following a thorough radical operation, 5-year survival is about 40%. Biliary cirrhosis

Surgery Local lymph node metastases (N1) are not an absolute contraindication to surgical treatment, because they do not significantly influence outcomes in hilar CCA

GB cancer Predominantly in the elderly Incidentally diagnosed at an early stage after cholecystectomy for cholelithiasis (1%) Approximately 90% of patients have gallstones. The 20-year risk of developing cancer for patients with gallstones is less than 0.5% for the overall population and 1.5% for high-risk groups

Risk Factors Larger stones (3 cm) tenfold increased risk The risk is higher in patients with symptomatic pts Polypoid lesions, particularly in polyps >10mm The calcified "porcelain" gallbladder (20%) selective mucosal calcification (7%) Choledochal cysts have an increased risk of developing cancer anywhere in the biliary tree, but the incidence is highest in the gallbladder.

Other Risk Factors Anomalous pancreatobiliary duct junction Obesity and pregnancy Chronic inflammatory bowel disease Polyposis coli Mirizzi syndrome Bacterial and Salmonella infections Industrial exposure to carcinogens Familial tendency

Pathology Adenocarcinomas 90%. Squamous cell, adenosquamous, oat cell, … Papillary (10%), nodular, and tubular Lymphatics are present in the subserosal layer only. Therefore cancers invading but growing through the muscular layer have minimal risk of nodal disease 40% have distant metastasis at Dx

Presentation Abdominal discomfort, right upper quadrant pain, nausea, and vomiting. Jaundice, weight loss, anorexia, ascites, and mass Blood work Imaging (UD, CT, MRI/MRCP, ERCP, PTC, PET/CT)

AJCC staging Stage 0: Carcinoma in situ Stage I: T1/2 N0 M0: invades lamina propria, muscle layer, perimuscular connective tissue Stage II: T3 N0/1 M0 T3: perforates the serosa and/or directly invades the liver and/or one adjacent organ Stage III: T4: invades any main vessel Stage IV: M1: distant metastases, including metastases in lymph nodes at the pancreatic body and tail

Treatment and prognosis Surgery Adjuvant therapy The 5-year survival rate of all patients is less than 5%, median survival of 6 months. T1 treated with cholecystectomy 90% 5-year survival T2 lesions treated with an extended cholecystectomy and lymphadenectomy is over 70% Advanced but resectable gallbladder cancer are reported to have 5-year survival rates of 20 to 50%.

Surgery Lap vs. open Post Lap Choly